Richard L Elliott
Overview
Explore the profile of Richard L Elliott including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
83
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chan B, Seward E, Lainchbury M, Brewer T, An L, Blench T, et al.
ACS Med Chem Lett
. 2022 Jan;
13(1):84-91.
PMID: 35059127
Hematopoietic progenitor kinase 1 (HPK1) is implicated as a negative regulator of T-cell receptor-induced T-cell activation. Studies using HPK1 kinase-dead knock-in animals have demonstrated the loss of HPK1 kinase activity...
2.
Bowman K, OShea J, Elliott R
J Med Assoc Ga
. 2018 Sep;
106(1):16-17.
PMID: 30251781
No abstract available.
3.
4.
5.
6.
Safina B, Elliott R, Forrest A, Heald R, Murray J, Nonomiya J, et al.
ACS Med Chem Lett
. 2017 Sep;
8(9):936-940.
PMID: 28947940
A novel selective benzoxazepin inhibitor of PI3Kδ has been discovered. Beginning from compound , an αPI3K inhibitor, we utilized structure-based drug design and computational analysis of dihedral torsion angles to...
7.
Chan B, Hanan E, Bowman K, Bryan M, Burdick D, Chan E, et al.
J Med Chem
. 2016 Aug;
59(19):9080-9093.
PMID: 27564586
Inhibitors targeting the activating mutants of the epidermal growth factor receptor (EGFR) have found success in the treatment of EGFR mutant positive non-small-cell lung cancer. A secondary point mutation (T790M)...
8.
9.
10.